These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25600955)

  • 61. Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies.
    Czobor P; Van Dorn RA; Citrome L; Kahn RS; Fleischhacker WW; Volavka J
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1158-66. PubMed ID: 26004980
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Do patients with schizophrenia distinguish between attitudes toward antipsychotic medication and pharmacotherapy in general? Validation of the Beliefs About Medication Questionnaire.
    Beck EM; Vögelin R; Wirtz M; Cavelti M; Kvrgic S; Vauth R
    J Nerv Ment Dis; 2012 Jan; 200(1):33-43. PubMed ID: 22210360
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Risk profiles for non-adherence to antipsychotic medications.
    McCann TV; Boardman G; Clark E; Lu S
    J Psychiatr Ment Health Nurs; 2008 Oct; 15(8):622-9. PubMed ID: 18803735
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The influence of therapeutic alliance and insight on medication adherence in schizophrenia.
    Misdrahi D; Petit M; Blanc O; Bayle F; Llorca PM
    Nord J Psychiatry; 2012 Feb; 66(1):49-54. PubMed ID: 21830849
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long- and short-term inpatients with schizophrenia in China: implications for community-based service development.
    Wu G; Ouyang X; Yang B; Li L; Wang Z; Yi W; Liu C; Wang P; Chiu HF; Lee E; Xue Z; Rosenheck R; Liu Z
    Asia Pac Psychiatry; 2013 Mar; 5(1):E39-46. PubMed ID: 23857794
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.
    Swerdlow NR; Light GA; Cadenhead KS; Sprock J; Hsieh MH; Braff DL
    Arch Gen Psychiatry; 2006 Dec; 63(12):1325-35. PubMed ID: 17146007
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
    J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Factors Affecting Medication Adherence Among Adults with Schizophrenia: A Literature Review.
    Tham XC; Xie H; Chng CM; Seah XY; Lopez V; Klainin-Yobas P
    Arch Psychiatr Nurs; 2016 Dec; 30(6):797-809. PubMed ID: 27888977
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of subjective illness beliefs and attitude toward recovery within the relationship of insight and depressive symptoms among people with schizophrenia spectrum disorders.
    Cavelti M; Beck EM; Kvrgic S; Kossowsky J; Vauth R
    J Clin Psychol; 2012 Apr; 68(4):462-76. PubMed ID: 22331634
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Descriptions and Correlates of Medication Adherence, Attitudes, and Self-Efficacy in Outpatients With Schizophrenia Spectrum Disorders (SSDs).
    Beebe LH; Smith K; Phillips C
    Arch Psychiatr Nurs; 2016 Jun; 30(3):400-5. PubMed ID: 27256948
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical correlates of early medication adherence: West London first episode schizophrenia study.
    Mutsatsa SH; Joyce EM; Hutton SB; Webb E; Gibbins H; Paul S; Barnes TR
    Acta Psychiatr Scand; 2003 Dec; 108(6):439-46. PubMed ID: 14616225
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Exploring the impact of depressive symptoms and medication beliefs on medication adherence in hypertension--a primary care study.
    Maguire LK; Hughes CM; McElnay JC
    Patient Educ Couns; 2008 Nov; 73(2):371-6. PubMed ID: 18692978
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia.
    Rocca P; Montemagni C; Castagna F; Giugiario M; Scalese M; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):373-9. PubMed ID: 19211031
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The relationship between cognitive insight, clinical insight, and depression in patients with schizophrenia.
    Ekinci O; Ugurlu GK; Albayrak Y; Arslan M; Caykoylu A
    Compr Psychiatry; 2012 Feb; 53(2):195-200. PubMed ID: 21489416
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Factors associated with medication non-adherence in patients suffering from schizophrenia: a cross-sectional study in a universal coverage health-care system.
    Dassa D; Boyer L; Benoit M; Bourcet S; Raymondet P; Bottai T
    Aust N Z J Psychiatry; 2010 Oct; 44(10):921-8. PubMed ID: 20932206
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Does adherence therapy improve medication adherence among patients with schizophrenia? A systematic review.
    Hegedüs A; Kozel B
    Int J Ment Health Nurs; 2014 Dec; 23(6):490-7. PubMed ID: 25279684
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of mindfulness-based psychoeducation on insight and medication adherence of schizophrenia patients.
    Çetin N; Aylaz R
    Arch Psychiatr Nurs; 2018 Oct; 32(5):737-744. PubMed ID: 30201202
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The impact of negative treatment experiences on persistent refusal of antipsychotics.
    Lincoln TM; Jung E; Wiesjahn M; Wendt H; Bock T; Schlier B
    Compr Psychiatry; 2016 Oct; 70():165-73. PubMed ID: 27552661
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Exploring predictors of medication adherence among inpatients with schizophrenia in Singapore's mental health settings: A non-experimental study.
    Tham XC; Xie H; Chng CML; Seah XY; Lopez V; Klainin-Yobas P
    Arch Psychiatr Nurs; 2018 Aug; 32(4):536-548. PubMed ID: 30029745
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Schizophrenia medication adherence in a resource-poor setting: randomised controlled trial of supervised treatment in out-patients for schizophrenia (STOPS).
    Farooq S; Nazar Z; Irfan M; Akhter J; Gul E; Irfan U; Naeem F
    Br J Psychiatry; 2011 Dec; 199(6):467-72. PubMed ID: 22130748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.